Association of diabetes mellitus with non-Hodgkin lymphoma risk: a meta-analysis of cohort studies

References

• Chihara D, Nastoupil LJ, Williams JN, et al. New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy. Expert Rev Anticancer Ther. 2015;15(5):531–544. doi: 10.1586/14737140.2015.1023712
   PubMed Web of Science ®Google Scholar
• Chiu BCH, Weisenburger DD. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma. 2003;4(3):161–168. doi: 10.3816/CLM.2003.n.025
   PubMedGoogle Scholar
• Smedby KE, Askling J, Mariette X, et al. Autoimmune and inflammatory disorders and risk of malignant lymphomas – an update. J Intern Med. 2008;264(6):514–527. doi: 10.1111/j.1365-2796.2008.02029.x
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053. doi: 10.2337/diacare.27.5.1047
   PubMed Web of Science ®Google Scholar
• Goff DC, Jr., Gerstein HC, et al. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the action to control cardiovascular risk in diabetes (ACCORD) trial. Am J Cardiol. 2007;99(12A):4i–20i. doi: 10.1016/j.amjcard.2007.03.002
   PubMed Web of Science ®Google Scholar
• James MT, Grams ME, Woodward M, et al. A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am J Kidney Dis. 2015;66(4):602–612. doi: 10.1053/j.ajkd.2015.02.338
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Peters SA, Woodward M, et al. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care. 2016;39(2):300–307.
   PubMed Web of Science ®Google Scholar
• Pang Y, Kartsonaki C, Guo Y, et al. Diabetes, plasma glucose and incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies. Int J Cancer. 2017;140(8):1781–1788. doi: 10.1002/ijc.30599
   PubMed Web of Science ®Google Scholar
• Guraya SY. Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review. World J Gastroenterol. 2015;21(19):6026–6031. doi: 10.3748/wjg.v21.i19.6026
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Zheng ZJ, Shi R, et al. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(7):2347–2353. doi: 10.1210/jc.2012-1267
   PubMed Web of Science ®Google Scholar
• Lee JY, Jeon I, Lee JM, et al. Diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies. Eur J Cancer. 2013;49(10):2411–2423. doi: 10.1016/j.ejca.2013.02.025
   PubMed Web of Science ®Google Scholar
• Gang P J, Mo L, Lu Y, et al. Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis. Endocr Res. 2015;40(1):54–61. doi: 10.3109/07435800.2014.934961
   PubMed Web of Science ®Google Scholar
• Lee JY, Jeon I, Kim JW, et al. Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies. Int J Gynecol Cancer. 2013 Mar;23(3):402–412. doi: 10.1097/IGC.0b013e31828189b2
   PubMed Web of Science ®Google Scholar
• Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121(4):856–862. doi: 10.1002/ijc.22717
   PubMed Web of Science ®Google Scholar
• Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50(7):1365–1374. doi: 10.1007/s00125-007-0681-5
   PubMed Web of Science ®Google Scholar
• Mitri J, Castillo J, Pittas AG. Diabetes and risk of non-Hodgkin's lymphoma: a meta-analysis of observational studies. Diabetes Care. 2008;31(12):2391–2397. doi: 10.2337/dc08-1034
   PubMed Web of Science ®Google Scholar
• Khan M, Mori M, Fujino Y, et al. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan collaborative cohort (JACC) study. Asian Pac J Cancer Prev. 2006;7(2):253–259.
   PubMedGoogle Scholar
• Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg. 2011;39(2):91–92. doi: 10.1016/j.jcms.2010.11.001
   PubMed Web of Science ®Google Scholar
• Lo CK, Mertz D, Loeb M. Newcastle-Ottawa scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14:45. doi: 10.1186/1471-2288-14-45
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45(Pt A):139–145. doi: 10.1016/j.cct.2015.09.002
   PubMed Web of Science ®Google Scholar
• Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Making. 2005;25(6):646–654. doi: 10.1177/0272989X05282643
   PubMed Web of Science ®Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997 Nov 1;127(9):820–826. doi: 10.7326/0003-4819-127-9-199711010-00008
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J. 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101. doi: 10.2307/2533446
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Wallace RB, Folsom AR, et al. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst. 1997;89(4):314–318. doi: 10.1093/jnci/89.4.314
   PubMedGoogle Scholar
• Khan AE, Gallo V, Linseisen J, et al. Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European prospective investigation into cancer and nutrition. Haematologica. 2008;93(6):842–850. doi: 10.3324/haematol.12297
   PubMed Web of Science ®Google Scholar
• Erber E, Lim U, Maskarinec G, et al. Common immune-related risk factors and incident non-hodgkin lymphoma: the multiethnic cohort. Int J Cancer. 2009;125(6):1440–1445. doi: 10.1002/ijc.24456
   PubMed Web of Science ®Google Scholar
• Ogunleye AA, Ogston SA, Morris AD, et al. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer. 2009;101(7):1199–1201. doi: 10.1038/sj.bjc.6605240
   PubMed Web of Science ®Google Scholar
• Atchison EA, Gridley G, Carreon JD, et al. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer. 2011;128(3):635–643. doi: 10.1002/ijc.25362
   PubMed Web of Science ®Google Scholar
• Tseng CH. Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan. Metab Clin Exp. 2012;61(7):1003–1009. doi: 10.1016/j.metabol.2011.11.015
   PubMed Web of Science ®Google Scholar
• Wotton CJ, Yeates DG, Goldacre MJ. Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies. Diabetologia. 2011;54(3):527–534. doi: 10.1007/s00125-010-1987-2
   PubMed Web of Science ®Google Scholar
• Lai GY, Park Y, Hartge P, et al. The association between self-reported diabetes and cancer incidence in the NIH-AARP diet and health study. J Clin Endocrinol Metab. 2013;98(3):E497–E502. doi: 10.1210/jc.2012-3335
   PubMed Web of Science ®Google Scholar
• Lo SF, Chang SN, Muo CH, et al. Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer. 2013;132(1):182–188. doi: 10.1002/ijc.27597
   PubMed Web of Science ®Google Scholar
• Wang M, Hu RY, Wu HB, et al. Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China. Sci Rep. 2015;5:11503. doi: 10.1038/srep11503
   PubMed Web of Science ®Google Scholar
• Yang WS, Li HL, Xu HL, et al. Type 2 diabetes and the risk of non-Hodgkin's lymphoma: a report from two population-based cohort studies in China. Eur J Cancer Prev. 2016;25(2):149–154. doi: 10.1097/CEJ.0000000000000150
   PubMed Web of Science ®Google Scholar
• Saarela K, Tuomilehto J, Sund R, et al. Cancer incidence among Finnish people with type 2 diabetes during 1989–2014. Eur J Epidemiol. 2018;34(3):259–265. doi: 10.1007/s10654-018-0438-0
   PubMed Web of Science ®Google Scholar
• Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer. 2011;47(16):2422–2430. doi: 10.1016/j.ejca.2011.06.029
   PubMed Web of Science ®Google Scholar